1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow HTLV-I Infection: new trials by email Literature Review of HTLV-I Infection trials Research Report on HTLV-I Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Tac for Treatment of Leukemia daclizumab - HTLV-I Infection, T Cell Leukemia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 1999-12-01 | 2012-08-20 |
Diabetes Mellitus, Insulin-Dependent, 10 (1) · HTLV-I Infections (1) · Leukemia, T-Cell (1) · Leukemia-Lymphoma, Adult T-Cell (1)
Deltaretrovirus Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Immunoproliferative Disorders (1) · Infections (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · RNA Virus Infections (1) · Retroviridae Infections (1)
Daclizumab (1)
National Cancer Institute (NCI) (1)
United States (1)